Zobrazeno 1 - 10
of 680
pro vyhledávání: '"Helio S. Sader"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Bloodstream infection (BSI) is associated with poor outcomes especially when effective antimicrobial therapy and control of infection source are delayed. As the frequency of Enterobacterales producing metallo-β-lactamases (MBL) a
Externí odkaz:
https://doaj.org/article/a98da34197b84688bdabda89653527cc
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 11 (2024)
ABSTRACT This study reports the activity of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. isolates collected from the United States and Europe, including Israel and Turkey, from 2020 to 2021. Among Enterobactera
Externí odkaz:
https://doaj.org/article/765cb9d27be34b02b8cbe9c652e4ce3f
Publikováno v:
Antibiotics, Vol 13, Iss 6, p 564 (2024)
We evaluated the activities of aztreonam/avibactam and recently approved β-lactamase inhibitor combinations (BLICs) to compare the antimicrobial susceptibility patterns of Enterobacterales and Pseudomonas aeruginosa isolated from intensive care unit
Externí odkaz:
https://doaj.org/article/08871ef02f3243d7b65bcb044824b4f6
Publikováno v:
International Journal of Infectious Diseases, Vol 116, Iss , Pp 306-312 (2022)
ABSTRACT: Background: High-dose cefepime-tazobactam (WCK 4282) is currently under clinical development at a dosage of 2 grams/2 grams every 8 hours with prolonged infusion (90 minutes). Objective: To evaluate the in vitro activity of high-dose cefepi
Externí odkaz:
https://doaj.org/article/5081ff46a758456c84fd75e8958c5a56
Autor:
Michael A. Pfaller, Dee Shortridge, Kelly A. Harris, Mark W. Garrison, C. Andrew DeRyke, Daryl D. DePestel, Pamela A. Moise, Helio S. Sader
Publikováno v:
International Journal of Infectious Diseases, Vol 112, Iss , Pp 321-326 (2021)
ABSTRACT: Objectives: To report on the activity of ceftolozane-tazobactam and comparators against Pseudomonas aeruginosa isolates collected from hospitalized patients with pneumonia in US intensive care units (ICUs) between 2015 and 2018. Activity ag
Externí odkaz:
https://doaj.org/article/cf72f849d8a4498eace2fdbed29e04ca
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 92-100 (2021)
Objectives: The antimicrobial activity of tedizolid and comparators was evaluated against a large worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae isolates recovered from patients with pneumonia. Methods: Clinical isolates w
Externí odkaz:
https://doaj.org/article/5767835ccdce4456a8c641299cbf2705
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 279-281 (2021)
Background: The limited armamentarium against multidrug-resistant Gram-negative bacilli led to the development of a new generation of β-lactam/β-lactamase inhibitor combinations (BL/BLI). Objectives: To evaluate the in vitro activity of ceftazidime
Externí odkaz:
https://doaj.org/article/bf9c27dc44894de6a4e64077bcd0288a
Autor:
Helio S. Sader, Cecilia G. Carvalhaes, Jennifer M. Streit, S.J. Ryan Arends, Rodrigo E. Mendes
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 24, Iss , Pp 48-52 (2021)
Objectives: To evaluate the in vitro activity of dalbavancin compared with vancomycin, daptomycin and other agents against a large collection of coagulase-negative staphylococci (CoNS) isolates. Methods: A total of 5088 CoNS causing clinically signif
Externí odkaz:
https://doaj.org/article/919522e538344c2587d60fde2191e6c7
Publikováno v:
International Journal of Infectious Diseases, Vol 102, Iss , Pp 524-528 (2021)
Objective: To evaluate the antimicrobial activity of ceftaroline against Staphylococcus aureus isolated from patients with infective endocarditis (IE). Methods: 23,833 S. aureus isolates were collected consecutively from patients with bloodstream inf
Externí odkaz:
https://doaj.org/article/97362aa537324e7c9b3a149bd9eeb41c
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss , Pp 69-71 (2021)
The activities of dalbavancin and comparator agents were evaluated against Staphylococcus aureus isolated from the lower respiratory tract of cystic fibrosis (CF) and non-CF patients with pneumonia. Bacterial isolates (n = 357) were collected from CF
Externí odkaz:
https://doaj.org/article/c76fc1d89024419c8cb4b0569ee2f118